Better Safety Info in Pregnancy Starts with Your Referral
Dermatologists need more information on the safety of medications when used in pregnancy. MotherToBaby Pregnancy Studies has over 20 years of experience conducting pregnancy exposure cohort studies. With your patient referrals, our research will produce the scientific evidence you and your patients need to weigh the risks and benefits of given treatments for both mom and baby, allowing you to make informed decisions that minimize maternal and fetal/infant risk.
Rigorously Designed Research Studies
We partner with physicians and patients to monitor pregnancy exposure to psoriasis and atopic dermatitis medications. Our strong cohort study design allows our team to tease apart risks that may be associated with underlying disease versus those associated with a medication exposure.
Please consider referring your patients if they fall into either of these two groups:
1. Patients who have taken any of the following medications during a current pregnancy:
- Cimzia® (Certolizumab-Pegol)
- Dupixent® (Dupilumab)
- Ilumya™ (Tildrakizumab)
- Otezla® (Apremilast)
- Tremfya® (Guselkumab)
2. Patients who have psoriasis, psoriatic arthritis or atopic dermatitis and have not taken the above medications during pregnancy.
Referral Is Easy & Patient Self-Enrolls
Refer: All you need to do is refer your patients to us. Women self-enroll, so after you make the referral nothing further is required from you.
Observation: Our research is by observation only — we will not ask your patient to take or change any medications or change any part of her healthcare routine
Participation: Women complete 1-3 phone interviews during pregnancy and at least 1 after pregnancy, and authorize the release of medical records for the pregnancy and for their baby.
Patient Education & Provider Resources for Dermatologists
MotherToBaby is a service of the non-profit Organization of Teratology Information Specialists (OTIS). In addition to conducting pregnancy registry studies, we are dedicated to providing no-cost evidence-based information to mothers and health professionals about medications and other exposures during pregnancy and while breastfeeding. We can provide you with patient and provider resources including:
- Patient-friendly Fact Sheets
- Patient Brochures
- Teratogen Information Services
Find out more by contacting our team. Our staff is dedicated to supporting healthcare professionals. Please select if you would like to learn more about patient referrals or to learn more about our resources.
"*" indicates required fields
MotherToBaby Pregnancy Studies are conducted by the Organization of Teratology Information Specialists (OTIS) and coordinated by the University of California San Diego. MotherToBaby is listed as a resource for information about medications in pregnancy by the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).